Endogenous arginase 2 as a biomarker for PEGylated arginase 1 treatment in squamous cell lung carcinoma xenograft models.
Published date:
05/16/2018
Excerpt:
The in vivo effect of PEGylated arginase 1 was studied using 3 lung SCC xenograft models (SK-MES-1, SW900 and H520)....PEGylated arginase 1 treatment was effective in lung SCC xenograft with low endogenous ARG2 expression.